Washington, D.C.—A prohibition on the use of trans fat as an ingredient in food products could be coming from the U.S. Food and Drug Administration (FDA). By removing the generally recognized as safe (GRAS) designation from trans fat, the agency would, in effect, make its inclusion illegal.
The updated food safety rules proposed by the U.S. Food and Drug Administration (FDA) are being criticized by many parties, especially small farmers. The rules, which are mandated by the Food Safety Modernization Act (FSMA), had their public comment period extended after technical issues prevented users from uploading comments to the Web site.
London—Although about 70% of the work done in agriculture is performed by women, their contributions often go unrecognized and underpaid, according to a new report collaborated on by the ethical trade group Twin and the Fairtrade Foundation, both based here. Empowering Women Farmers in Agricultural Value Chains details the glass ceiling women farmers face in the food industry, and what can be done to improve their status.
Chicago, IL—A whopping 65% of consumers who have tried gluten-free foods said they did so in part because they thought they were healthier, according to new research from Mintel. Perhaps more interesting are the 27% of consumers who responded that they eat gluten free as part of their efforts to lose weight.
Even with its approval by the U.S. Food and Drug Administration (FDA) seeming imminent, genetically-engineered (GE) AquAdvantage salmon has been dealt a major blow. Several large national retailers made commitments to deny AquAdvantage, produced by Massachusetts-based AquaBounty Technologies, entrance into their stores.
Omaha, NE—The U.S. Food and Drug Administration (FDA) informed ConAgra Foods, Inc. that it will allow a qualified health claim linking whole grains with reduced risk of type-2 diabetes. The decision comes after the company petitioned the agency in 2012 to use a similar claim in its own wording. The new allowable health claim wording is very cautious, however, and FDA will assess on an individual basis whether any instances of the claim on food packaging are misleading to consumers.
Washington, D.C.—A controversial provision that critics named the “Monsanto Protection Act” was stopped in its tracks when it was removed from the spending resolution Congress was engrossed with in late September. U.S. Senators Barbara Mikulski (D-MD) and Jeff Merkley (D-OR) successfully pushed to have the item in question, Sec. 735, removed from the Senate version of the bill. The provision was set to expire at the end of September 2013.